Eton Pharmaceuticals Inc
NASDAQ:ETON
Eton Pharmaceuticals Inc
NASDAQ:ETON
Price:
17.0725
USD
-2.61%
Market Cap:
$457.9m
Balance Sheet
Balance Sheet Decomposition
Eton Pharmaceuticals Inc
Eton Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
Eton Pharmaceuticals Inc
Eton Pharmaceuticals Inc
Balance Sheet
Eton Pharmaceuticals Inc
Eton Pharmaceuticals Inc
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
13
|
27
|
12
|
21
|
14
|
16
|
21
|
15
|
|
| Cash Equivalents |
13
|
27
|
12
|
21
|
14
|
16
|
21
|
15
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
5
|
2
|
3
|
5
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
5
|
2
|
3
|
5
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
15
|
|
| Other Current Assets |
0
|
1
|
2
|
2
|
3
|
1
|
1
|
5
|
|
| Total Current Assets |
13
|
28
|
15
|
25
|
24
|
20
|
27
|
41
|
|
| PP&E Net |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
1
|
1
|
4
|
5
|
5
|
35
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
13
N/A
|
28
+111%
|
17
-40%
|
26
+54%
|
27
+4%
|
25
-9%
|
32
+27%
|
76
+140%
|
|
| Liabilities | |||||||||
| Accounts Payable |
1
|
1
|
1
|
2
|
2
|
2
|
2
|
4
|
|
| Accrued Liabilities |
0
|
1
|
1
|
1
|
1
|
4
|
9
|
16
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
1
|
5
|
0
|
|
| Total Current Liabilities |
1
|
2
|
2
|
4
|
5
|
6
|
16
|
20
|
|
| Long-Term Debt |
0
|
0
|
5
|
7
|
5
|
5
|
0
|
30
|
|
| Other Liabilities |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Total Liabilities |
1
N/A
|
2
+54%
|
7
+223%
|
11
+63%
|
10
-8%
|
12
+21%
|
16
+36%
|
52
+218%
|
|
| Equity | |||||||||
| Common Stock |
19
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
9
|
46
|
64
|
92
|
94
|
103
|
104
|
108
|
|
| Additional Paid In Capital |
2
|
72
|
75
|
108
|
112
|
116
|
120
|
132
|
|
| Total Equity |
12
N/A
|
26
+117%
|
11
-60%
|
16
+48%
|
18
+13%
|
13
-26%
|
15
+18%
|
24
+58%
|
|
| Total Liabilities & Equity |
13
N/A
|
28
+111%
|
17
-40%
|
26
+54%
|
27
+4%
|
25
-9%
|
32
+27%
|
76
+140%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
16
|
18
|
18
|
24
|
25
|
25
|
26
|
27
|
|
Switch to:
Switch to:
See Also
Discover More
